2 型糖尿病藥物：全球市場展望

在本報告中，我們調查了全球 2 型糖尿病治療市場、市場背景、各種影響市場增長的因素分析、市場規模的轉變和預測，以及每個細分市場、地區和主要國家的詳細信息。分析彙編、競爭格局、主要公司概況等。

內容

第一章市場展望

• 市場概況

第 2 章執行摘要

第 3 章市場概述

• 2 型糖尿病概述
• 市場驅動因素
• 市場挑戰
• COVID-19 的影響

第 4 章新趨勢和機遇

• 超出血糖控制範圍的患者的結局
• 糖尿病技術通過數字健康
• 口服抗糖尿病藥的發展趨勢
• 更加關注醫療保健的可及性和可負擔性

第 5 章市場細分：按給藥途徑和治療類型

• 2 型糖尿病藥物市場：按給藥途徑分類
  • 市場規模和預測
• 可注射藥物市場：按類型分類
  • 胰島素治療
  • 胰高血糖素樣□ 1 療法
  • 市場規模和預測
• 口服藥物市場：按藥物類別分類
  • 二□基□□ 4 抑製劑
  • 鈉-葡萄糖協同轉運蛋白 2 抑製劑
  • 胰高血糖素樣□ 1 受體激動劑
  • 其他
  • 市場規模和預測
• 2 型糖尿病藥物市場：按治療類型分類
  • 市場規模和預測
• 胰島素治療市場：按胰島素類型
  • 市場規模和預測
• 非胰島素療法市場：按藥物類型分類
  • 市場規模和預測

第 6 章市場細分：按地區

• 2 型糖尿病藥物市場規模：按地區
• 北美
• 歐洲
• 亞太地區
• 其他地區

第七章競爭格局

• 主要公司的市場份額
• 近期的主要發展
• 來自暢銷抗糖尿病藥物和治療的收入
• 專利懸崖

第八章公司簡介

• ASTRAZENECA PLC
• BIOCON
• BOEHRINGER INGELHEIM INTERNATIONAL GMBH
• ELI LILLY AND CO.
• JANSSEN PHARMACEUTICALS INC.（JOHNSON & JOHNSON）
• MERCK & CO., INC.
• NOVARTIS AG
• NOVO NORDISK A/S
• SANOFI

第九章項目範圍及調查方法

Highlights:

The goal is to provide an up-to-date analysis of the global type 2 diabetes treatment market and future opportunities in the market. It presents a thorough and up-to-date global assessment of the market and business of type 2 diabetes treatment. This will help industry participants, suppliers, government bodies, associations, and customers make the informed decisions needed to compete and succeed in the marketplace. The scope of the study includes the various types of medicines involved in type 2 diabetes treatment and management. Blood glucose monitoring, diagnostic systems and devices, and insulin-delivery devices used in the treatment of type 2 diabetes, however, have been excluded from this study.

Report Scope:

In this report, the market has been segmented based on route of administration, therapy type and region. The report provides an overview of the global type 2 diabetes treatment market and analyses market trends. Using 2021 as the base year, it provides estimated market data for the forecast period of 2022 to 2027. Revenue forecasts for this period are segmented based on route of administration, therapy type and geography. Market values have been estimated based on the total revenue of type 2 diabetes therapies providers.

The report covers the market for type 2 diabetes treatment with regard to the therapy type across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. It estimates the global market for type 2 diabetes treatment in 2021, and then provides projections for the expected market size through 2027.

The scope of the study includes the various types of medicines involved in type 2 diabetes treatment and management. Blood glucose monitoring, diagnostic systems and devices, and insulin-delivery devices used in the treatment of type 2 diabetes, however, have been excluded from this study.

Report Includes:

• A comprehensive overview of the global market for the treatment of type 2 diabetes
• Analyses of the global and regional market trends, with historic revenue data from 2019 to 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2027
• Understanding of the current and future market potential for this innovation driven market, and areas of focus to forecast the market into various segments and sub-segments
• Discussion of the industry growth driving factors and challenges that will shape the market for type 2 diabetes treatment as the basis for projecting demand in the next few years (2022-2027)
• Estimation of the actual market size and revenue forecast for global type 2 diabetes treatment market, and corresponding market share analysis by therapy type, route of administration, end user, and region
• Holistic review of the COVID-19 pandemic implications on the global market for treatment of type 2 diabetes
• Review of the patent grants and patent applications on type 2 diabetes treatment solutions and related technologies
• Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues

Table of Contents

Chapter 1 Market Outlook

• 1.1 Market Snapshot

Chapter 2 Executive Summary

Chapter 3 Market Overview

• 3.1 Type 2 Diabetes Overview
  • 3.1.1 What is Type 2 Diabetes?
  • 3.1.2 Prevalence and Epidemiology of Type 2 Diabetes
  • 3.1.3 Diagnosing Type 2 Diabetes
  • 3.1.4 Treatment for Type 2 Diabetes
• 3.2 Market Drivers
  • 3.2.1 Rising Prevalence of Diabetes
  • 3.2.2 Next Generation of Type 2 Diabetes Treatment
  • 3.2.3 High Unmet Need
  • 3.2.4 Premium Pricing
  • 3.2.5 Collaborations and Licensing Agreements
• 3.3 Market Challenge
  • 3.3.1 Loss of Exclusivity, Genericization and Pricing Pressure
  • 3.3.2 Evolving Regulatory Scenario
• 3.4 Impact of COVID-19

Chapter 4 Emerging Trends and Opportunities

• 4.1 Patient Outcomes Beyond Glucose Control
• 4.2 Diabetes Technology with Digital Health
• 4.3 Growing Trend Toward Oral Antidiabetics
• 4.4 Growing Focus on Accessibility and Affordability of Medicine

Chapter 5 Market Breakdown by Route of Administration and Therapy Type

• 5.1 Type 2 Diabetes Treatment Market by Route of Administration
  • 5.1.1 Market Size and Forecast
• 5.2 Injectable Therapies Market by Type
  • 5.2.1 Insulin Therapy
  • 5.2.2 Glucagon-Like Peptide 1 Therapy
  • 5.2.3 Market Size and Forecast
• 5.3 Oral Medications Market by Drug Class
  • 5.3.1 Dipeptidyl Peptidase-4 Inhibitors
  • 5.3.2 Sodium-Glucose Cotransporter-2 Inhibitors
  • 5.3.3 Glucagon-Like Peptide 1 Receptor Agonists
  • 5.3.4 Other Oral Antidiabetic Medications
  • 5.3.5 Market Size and Forecast
• 5.4 Type 2 Diabetes Treatment Market by Therapy Type
  • 5.4.1 Market Size and Forecast
• 5.5 Insulin Therapy Market by Insulin Type
  • 5.5.1 Market Size and Forecast
• 5.6 Non-Insulin Therapies Market by Drug Type
  • 5.6.1 Market Size and Forecast

Chapter 6 Market Breakdown by Region

• 6.1 Type 2 Diabetes Treatment Market Size by Region
• 6.2 North America
• 6.3 Europe
• 6.4 Asia-Pacific
• 6.5 Rest of the World

Chapter 7 Competitive Landscape

• 7.1 Global Market Shares of Leading Companies
• 7.2 Recent Key Developments
• 7.3 Blockbuster Diabetes Drug and Therapy Revenue
• 7.4 Facing the Patent Cliff

Chapter 8 Company Profiles

• ASTRAZENECA PLC
• BIOCON
• BOEHRINGER INGELHEIM INTERNATIONAL GMBH
• ELI LILLY AND CO.
• JANSSEN PHARMACEUTICALS INC. (JOHNSON & JOHNSON)
• MERCK & CO., INC.
• NOVARTIS AG
• NOVO NORDISK A/S
• SANOFI

Chapter 9 Project Scope and Methodology

• 9.1 Scope of Report
• 9.2 Methodology
• 9.3 Analyst's Credentials
• 9.4 BCC Custom Research
• 9.5 Related BCC Research Reports

List of Tables

• Summary Table : Global Market for Type 2 Diabetes Treatment, by Region, Through 2027
• Table 1 : Global Diabetes Estimates and Projections, 2019-2045
• Table 2 : Global Prevalence of Diabetes, by Type, Through 2040
• Table 3 : Age-Adjusted Comparative Prevalence of Diabetes, by Region, 2010-2040
• Table 4 : First-Time Generic Drug Approvals for Type 2 Diabetes, October 2022-2021
• Table 5 : Global Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
• Table 6 : Global Market for Injectable Therapies for Type 2 Diabetes, by Type, Through 2027
• Table 7 : Medications in the DPP-4 Inhibitor Family
• Table 8 : Medications in the SGLT2 Inhibitor Family
• Table 9 : Oral GLP-1 Receptor Agonists
• Table 10 : Global Market for Oral Medications for Type 2 Diabetes, by Drug Class, Through 2027
• Table 11 : Global Market for Type 2 Diabetes Treatment, by Therapy Type, Through 2027
• Table 12 : Insulin Types and Their Features
• Table 13 : Leading Insulin Products and Their Types
• Table 14 : Global Market for Insulin for Type 2 Diabetes Treatment, by Insulin Type, Through 2027
• Table 15 : Global Market for Non-Insulin Therapies for Type 2 Diabetes, by Drug Type, Through 2027
• Table 16 : Global Market for Type 2 Diabetes Treatment, by Region, Through 2027
• Table 17 : North American Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
• Table 18 : North American Market for Injectable Therapies for Type 2 Diabetes, by Therapy Type, Through 2027
• Table 19 : North American Market for Oral Medications Type 2 Diabetes, by Drug Class, Through 2027
• Table 20 : North American Market for Type 2 Diabetes Treatment, by Country, Through 2027
• Table 21 : European Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
• Table 22 : European Market for Injectable Therapies for Type 2 Diabetes, by Therapy Type, Through 2027
• Table 23 : European Market for Oral Medications Type 2 Diabetes, by Drug Class, Through 2027
• Table 24 : European Market for Type 2 Diabetes Treatment, by Country, Through 2027
• Table 25 : Asia-Pacific Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
• Table 26 : Asia-Pacific Market for Injectable Therapies for Type 2 Diabetes, by Therapy Type, Through 2027
• Table 27 : Asia-Pacific Market for Oral Medications Type 2 Diabetes, by Drug Class, Through 2027
• Table 28 : Asia-Pacific Market for Type 2 Diabetes Treatment, by Country, Through 2027
• Table 29 : RoW Market for Type 2 Diabetes Treatment, by Route of Administration, Through 2027
• Table 30 : RoW Market for Injectable Therapies for Type 2 Diabetes, by Therapy Type, Through 2027
• Table 31 : RoW Oral Medications Market for Type 2 Diabetes, by Drug Class, Through 2027
• Table 32 : RoW Type 2 Diabetes Treatment, by Sub-Region, Through 2027
• Table 33 : Global Market Shares of Type 2 Diabetes Therapies Manufacturers, 2021
• Table 34 : Global Type 2 Diabetes Treatment Market, Selected Recent Key Developments, September 2019-August 2022
• Table 35 : Global Sales of the Blockbuster Diabetes Drugs and Therapies, 2021
• Table 36 : Blockbuster Diabetes Therapies, by Therapy Type, 2021
• Table 37 : Global Evolution of the Top-Selling Diabetes Drug and Therapy Brands, 2016-2021
• Table 38 : U.S. Patent Expiry Dates for the Blockbuster Diabetes Drugs, 2021
• Table 39 : Astrazeneca: Product Portfolio for Type 2 Diabetes Treatment
• Table 40 : Astrazeneca: Selected Key Developments, 2020-October 2022
• Table 41 : Biocon: Product Portfolio for Type 2 Diabetes Treatment
• Table 42 : Biocon: Selected Key Developments, 2020-October 2022
• Table 43 : Boehringer Ingelheim: Products Portfolio for Type 2 Diabetes Treatment
• Table 44 : Boehringer Ingelheim: Selected Key Developments, 2019-October 2022
• Table 45 : Eli Lilly and Co.: Products Portfolio for Type 2 Diabetes Treatment
• Table 46 : Eli Lilly and Co.: Selected Key Developments, 2020-November 2022
• Table 47 : Janssen Pharmaceuticals: Products Portfolio for Type 2 Diabetes Treatment
• Table 48 : Merck & Co. Inc.: Products Portfolio for Type 2 Diabetes Treatment
• Table 49 : Merck & Co. Inc.: Selected Key Developments, 2020-October 2022
• Table 50 : Novartis: Products Portfolio for Type 2 Diabetes Treatment
• Table 51 : Novo Nordisk: Products Portfolio for Type 2 Diabetes Treatment
• Table 52 : Novo Nordisk: Selected Key Developments, 2019-October 2022
• Table 53 : Sanofi: Products Portfolio for Type 2 Diabetes Treatment
• Table 54 : Sanofi: Selected Key Developments, 2020-November 2022

List of Figures

• Summary Figure : Global Market Share of Type 2 Diabetes Treatment, by Region, 2021
• Figure 1 : Type 2 Diabetes Facts
• Figure 2 : Global Diabetes Incidence
• Figure 3 : Risk of Developing Diabetes-Related Comorbidities
• Figure 4 : Global Market Shares of Type 2 Diabetes Treatment, by Route of Administration, 2021
• Figure 5 : Global Market Shares of Injectable Therapies for Type 2 Diabetes, by Type, 2021
• Figure 6 : Global Market Shares of Oral Medications for Type 2 Diabetes, by Drug Class, 2021
• Figure 7 : Global Market Shares of Type 2 Diabetes Treatment, by Therapy Type, 2021
• Figure 8 : Global Market Shares of Insulin for Type 2 Diabetes Treatment, by Insulin Type, 2021
• Figure 9 : Global Market Shares of Non-Insulin Therapies for Type 2 Diabetes, by Drug Type, 2021
• Figure 10 : Global Type 2 Diabetes Treatment Market, by Region
• Figure 11 : Global Market Share of Type 2 Diabetes Treatment, by Region, 2021
• Figure 12 : Global Market Shares of Type 2 Diabetes Treatment, by Region, 2027
• Figure 13 : Global Market Shares of Type 2 Diabetes Therapies Manufacturers, 2021
• Figure 14 : Global Evolution of the Top-Selling Insulin Brands, 2016-2021
• Figure 15 : Global Evolution of the Top-Selling Non-Insulin Diabetes Drug Brands, 2016-2021